Proxsys Rx

MAY 1, 2023

Court of Appeals for the Third Circuit — which was largely in favor of three drug companies that have imposed harmful limits on safety-net hospitals’ access to 340B drug pricing program discounts. For more information, contact Howard Hall.

Drug Pricing

Proxsys Rx

APRIL 10, 2023

Court of Appeals for the Third Circuit — which was largely in favor of three drug companies that have imposed harmful limits on safety-net hospitals’ access to 340B drug pricing program discounts. For more information, contact Howard Hall.

Drug Pricing

Proxsys Rx

DECEMBER 11, 2023

At the same time, it’s no secret that, since the advent of 340B ESP in 2020, the drug manufacturers have imposed a raft of restrictions on 340B program savings that exist far outside the letter of the law as written by Congress in 1992. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies

Putting Patients First Blog

NOVEMBER 14, 2023

NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program (PDF) November 13, 2023 Benjamin Stidham, Contract Specialist Centers for Medicare & Medicaid Services U.S. Barriers to ensuring access to affordable prescription drugs. Sincerely, Randall L.

Drug Pricing

Drug Channels

JULY 6, 2020

Click here to see the original post and comments from March 2020. Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S.

Specialty Pharmacies

Drug Channels

JULY 6, 2020

Click here to see the original post and comments from March 2020. Next week, Drug Channels Institute will release our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. The exhibit below—one of 203 in our new report—provides a first look at the 15 largest pharmacies, ranked by total U.S.

Specialty Pharmacies

Drug Channels

FEBRUARY 23, 2021

Let’s melt away this foul February with our monthly selection of scorching news from around the drug channel. In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar!

Specialty Pharmacies

Proxsys Rx

MARCH 1, 2024

At the same time, it’s no secret that, since the advent of 340B ESP in 2020, the drug manufacturers have imposed a raft of restrictions on 340B program savings that exist far outside the letter of the law as written by Congress in 1992. Every specialty pharmacy patient you serve should be monitored by a clinic pharmacist.

Specialty Pharmacies

Proxsys Rx

APRIL 19, 2024

HRSA issues “Administrative Dispute Resolution” ruling On April 19, HRSA issued a ruling entitled “340B Drug Pricing Program; Administrative Dispute Resolution.” This ADR process should be an expeditious and less formal process for parties to resolve disputes than the 2020 final rule.

Specialty Pharmacies

Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). An assessment of regulatory interpretation of qualifying single-source drugs in Medicare negotiation.

Drug Pricing

Proxsys Rx

JANUARY 12, 2024

Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering. Some covered entities generate as much as 600% in revenue from 340B specialty drugs as they do in traditional retail / outpatient pharmacy 340B prescriptions.

Specialty Pharmacies

Ramblings of a pharmacist

FEBRUARY 16, 2022

Anyway – on to the current issue of the Digest (which is the 2021 Digest that summarizes data from 2020 operations). The Digest is a summary of voluntarily submitted data from pharmacy owners based on their internal financial statements and management statistics. in 2020. Grandpa’s 31,766th prescription.

Independent Pharmacies

Putting Patients First Blog

JANUARY 27, 2025

Consequences of Obesity, last reviewed May 15, 2023, [link] www.cdc.gov/obesity/basics/consequences.html 6 Libbi Green and Patty Taddei-Allen, “Shifting Paradigms: Reframing Coverage of Antiobesity Medications for Plan Sponsors,” Journal of Managed Care & Specialty Pharmacy 29, no. 1 (2020): 1624, [link] 31 U.S.

Insurance Coverage and Processing

Proxsys Rx

JUNE 4, 2025

The evolving legal and legislative landscape surrounding the 340B Drug Pricing Program has significant implications for hospitals’ specialty pharmacies. Here’s a breakdown of the new developments and their likely impacts: Recent 340B changes and their impact on specialty pharmacies 1.

Specialty Pharmacies